Blood test picks out prostate cancer drug resistance

6 Nov 2015
The Institute of Cancer Research

Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.

Please click here to read the 'Institute of Cancer Research' press release in full